Smerud Medical Research International AS

🇳🇴Norway
Ownership
-
Employees
-
Market Cap
-
Website

A Study of the Efficacy and Safety of 2PX in Patients With Pain Due to Osteoarthritis of the Knee

First Posted Date
2009-08-07
Last Posted Date
2010-03-24
Lead Sponsor
Smerud Medical Research International AS
Target Recruit Count
300
Registration Number
NCT00954629
Locations
🇵🇱

Site in Bialystok, Bialystok, Poland

🇵🇱

Site in Kraków, Kraków, Poland

🇷🇺

Site in St-Petersburg, St-Petersburg, Russian Federation

and more 11 locations

Study of the Efficacy, Safety and Tolerability of Topical 2PX (Strontium Chloride Hexahydrate) in Patients With Chronic, Moderate-to-severe Lower Limb Post-amputation Stump Pain

Phase 2
Conditions
Interventions
First Posted Date
2008-12-08
Last Posted Date
2010-03-24
Lead Sponsor
Smerud Medical Research International AS
Target Recruit Count
150
Registration Number
NCT00804375
Locations
🇬🇧

Site in Middlesborough, Middlesborough, United Kingdom

🇬🇧

Site in Birmingham, Birmingham, United Kingdom

🇬🇧

Site in Crystal Palace, London, United Kingdom

and more 16 locations

Ibandronate Versus Placebo in the Prevention of Bone Loss After Renal Transplantation.

First Posted Date
2007-01-18
Last Posted Date
2010-03-24
Lead Sponsor
Smerud Medical Research International AS
Target Recruit Count
130
Registration Number
NCT00423384
Locations
🇳🇴

Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway

© Copyright 2024. All Rights Reserved by MedPath